In this context, it is pivotal to explore novel molecules involving the regulatory function of VEGFA, which will provide additional targeted therapies combined with the existing strategies to overcome drug resistance and inhibit HCC angiogenesis. This evidence concerns the gene VEGFA and hepatocellular carcinoma.